• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 3. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines

Introduction to 4,4-Difluoro-1-methylpiperidine (CAS No. 1186194-60-4)

4,4-Difluoro-1-methylpiperidine (CAS No. 1186194-60-4) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, has shown promise in various applications, particularly in the development of novel therapeutic agents. The presence of fluorine atoms and a methyl group on the piperidine ring imparts distinct chemical and biological properties, making it a valuable building block in drug discovery and synthesis.

The chemical structure of 4,4-Difluoro-1-methylpiperidine consists of a piperidine ring with two fluorine atoms at the 4-position and a methyl group at the 1-position. The fluorine atoms introduce significant electronic and steric effects, which can influence the compound's reactivity and biological activity. These modifications can enhance the lipophilicity and metabolic stability of molecules derived from this scaffold, making it an attractive candidate for drug design.

Recent studies have highlighted the potential of 4,4-Difluoro-1-methylpiperidine in various therapeutic areas. For instance, research published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit potent anti-inflammatory properties. These derivatives were found to effectively inhibit key enzymes involved in inflammatory pathways, such as cyclooxygenase (COX) and lipoxygenase (LOX). This finding suggests that 4,4-Difluoro-1-methylpiperidine could serve as a lead compound for developing new anti-inflammatory drugs with improved efficacy and reduced side effects.

In addition to its anti-inflammatory potential, 4,4-Difluoro-1-methylpiperidine has also been explored for its neuroprotective properties. A study published in the European Journal of Pharmacology reported that certain derivatives of this compound can protect neurons from oxidative stress and neurotoxicity. These findings are particularly relevant in the context of neurodegenerative diseases such as Alzheimer's and Parkinson's disease, where oxidative stress plays a crucial role in disease progression.

The synthetic accessibility of 4,4-Difluoro-1-methylpiperidine is another factor contributing to its widespread use in pharmaceutical research. Several efficient synthetic routes have been developed to prepare this compound, including methods involving nucleophilic substitution reactions and palladium-catalyzed cross-coupling reactions. These synthetic strategies allow for the rapid and scalable production of 4,4-Difluoro-1-methylpiperidine, facilitating its incorporation into complex molecular architectures.

The pharmacokinetic properties of 4,4-Difluoro-1-methylpiperidine-based compounds have also been extensively studied. Research has shown that these compounds exhibit favorable absorption, distribution, metabolism, and excretion (ADME) profiles. For example, a study published in the Bioorganic & Medicinal Chemistry Letters demonstrated that certain derivatives of this compound have high oral bioavailability and good brain penetration, which are essential attributes for central nervous system (CNS) drugs.

In conclusion, 4,4-Difluoro-1-methylpiperidine (CAS No. 1186194-60-4) is a promising compound with diverse applications in medicinal chemistry and pharmaceutical research. Its unique structural features and favorable pharmacological properties make it an attractive scaffold for developing novel therapeutic agents. Ongoing research continues to uncover new possibilities for this compound, further solidifying its importance in the field.

• 144230-52-4(4,4-Difluoropiperidine hydrochloride)
• 783292-61-5(1-(2-Chloroethyl)-4,4-difluoropiperidine)
• 824413-96-9((4,4-Difluoropiperidin-yl)acetonitrile)
• 1416351-83-1(4-(4,4-Difluoro-piperidin-1-yl)-butyronitrile)
• 276862-11-4(2-(4,4-difluoropiperidin-1-yl)ethan-1-ol)
• 21987-29-1(4,4-Difluoropiperidine)
• 1416351-76-2(3-(4,4-Difluoro-piperidin-1-yl)-propionitrile)
• 686298-08-8(4,4-difluoro-1,4'-bipiperidine)
• 605659-03-8(2-(4,4-Difluoropiperidin-1-yl)ethanamine)
• 869493-53-8(3-(4,4-difluoropiperidin-1-yl)propan-1-amine)